Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Egg Allergy in Children Through Oral Desensitization (EGG OIT)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Between 1 to 16 years of age~* Diagnosed egg allergy by CAP FEIA to egg of 5 kU/l or greater (2 kU/l or greater if 2 years old or less) or have had a positive allergic reaction to egg within 6 months.~* Having eaten egg in his/her diet prior to diagnosis~* A family that will be able to be compliant with all study visits~* All females of child bearing age must be using appropriate birth control~Exclusion Criteria:~* History of anaphylaxis to egg~* Medical history that would prevent a DBPCFC (double-blind placebo-controlled food challenge) to egg. The medical history that would prevent the DBPCFC to egg would be a prior history of an open egg challenge in which the patient experienced hypotension which required fluid resuscitation, respiratory compromise which necessitated ventilatory support, or poorly controlled asthma as evidenced by an FEV1 \< 80% of predicted, or FEV1/FVC \<75%, with or without controller medications~* Unable to cooperate with challenge procedures or unable to be reached by telephone for follow-up~* Diagnosed corn allergy

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- Egg white protein (Type: EXPERIMENTAL): Subjects, who are egg allergic, are given egg white protein for desensitization with the hypothesis they will develop tolerance.

Based on this trial design, predict the completion outcome and termination type (if applicable).